Kerry Solomon

$Representative image of artificial intelligence in ophthalmology, illustrating how AI is moving into focus at the ASCRS 2026 Annual Meeting as cataract and refractive surgery leaders assess its clinical, ethical, and commercial future.$

Healthcare Industry News

AI in ophthalmology at ASCRS 2026: What the Washington DC meeting is signalling about the specialty’s technology future

Kerry Solomon's Binkhorst Lecture at ASCRS 2026 in Washington DC puts AI at the centre of ophthalmology. Coverage of Zeiss VisioGen, IOL calculators, and Sean Ianchulev's Kelman Lecture.

byVenkatesh

April 11, 2026

$Representative image of the ASCRS 2026 Annual Meeting in Washington, D.C., highlighting cataract and refractive surgery innovation, ophthalmic practice trends, and artificial intelligence in eye care.$

Pharma Industry News

ASCRS 2026 in Washington DC: What ophthalmologists need to know

ASCRS 2026 annual meeting runs April 10-13 in Washington DC. Full guide to the programme, key speakers, technology announcements, SightLine, and CME for anterior segment surgeons.

byPallavi Madhiraju

April 11, 2026

Healthcare Industry News

Alcon launches AcrySof IQ PanOptix trifocal intraocular lens for cataract surgery patients in US

Alcon, a leading global eye care company, has introduced its AcrySof IQ PanOptix trifocal intraocular lens (IOL) in…

bypharmanewsdaily

October 13, 2019

The Latest

Brookfield completes $3bn Oaktree buyout as credit platform reaches $365 bn

Williams to buy Momentum Midstream for $5.5bn as Haynesville LNG strategy accelerates

Snap revenue jumps 19% as AI advertising tools revive $SNAP investor confidence

Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test

AI in ophthalmology at ASCRS 2026: What the Washington DC meeting is signalling about the specialty’s technology future

ASCRS 2026 in Washington DC: What ophthalmologists need to know

Alcon launches AcrySof IQ PanOptix trifocal intraocular lens for cataract surgery patients in US

Brookfield completes $3bn Oaktree buyout as credit platform reaches $365 bn

Williams to buy Momentum Midstream for $5.5bn as Haynesville LNG strategy accelerates

Snap revenue jumps 19% as AI advertising tools revive $SNAP investor confidence

Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test

Flotek secures 10-year Puerto Rico power role as $400m backlog tests PWRtek strategy

Qualcomm’s $3.1bn Modular deal puts AI software at centre of data centre push

Ballymore Resources (ASX: BMR) extends Torpy’s high-grade silver system as 20 drill assays remain pending

Braveheart Bio IPO targets $1.2bn valuation as HCM drug race heats up